Anthelmin Comprimidos para cães grandes
Anthelmin Comprimidos para cães grandes
Authorised
- Febantel
- Pyrantel embonate
- Praziquantel
Product identification
Medicine name:
Anthelmin Comprimidos para cães grandes
Active substance:
- Febantel
- Pyrantel embonate
- Praziquantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Febantel525.00milligram(s)1.00Tablet
-
Pyrantel embonate504.00milligram(s)1.00Tablet
-
Praziquantel175.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC55
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Portugal
Package description:
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
- Available only in Portuguese
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- KRKA tovarna zdravil d.d. Novo mesto
- Krka-Farma d.o.o.
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- 994/02/16NFVPT
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Portuguese (PDF)
Published on: 27/05/2022
How useful was this page?: